New hope for kids with hard-to-treat leukemia: triple-drug combo enters trials
Disease control
Not yet recruiting
This study tests a combination of three drugs (capivasertib, venetoclax, and dexamethasone) in children and young adults up to age 21 whose leukemia or lymphoma has returned or not responded to treatment. The goal is to find the safest dose and see how well the drugs shrink or cl…
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Apr 29, 2026 03:41 UTC